Voyager Therapeutics (VYGR) Long-Term Investments (2015 - 2026)

Voyager Therapeutics (VYGR) has 9 years of Long-Term Investments data on file, last reported at $30.2 million in Q1 2026.

• For the quarter ending Q1 2026, Long-Term Investments fell 48.93% year-over-year to $30.2 million; the trailing twelve-month figure through Mar 2026 stood at $30.2 million (down 48.93% YoY), and the FY2025 full-year result was $5.2 million, down 92.02% from the prior year.
• Long-Term Investments improved to $30.2 million in Q1 2026, from $5.2 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $65.7 million in Q4 2024 to a low of $980000.0 in Q1 2024.
• A 3-year average of $32.5 million and a median of $30.2 million in 2026 frame the typical range for Long-Term Investments.
• Peak annual rise in Long-Term Investments reached 5930.92% in 2025, while the deepest fall reached 92.02% in 2025.
• Tracing VYGR's Long-Term Investments over 3 years: stood at $65.7 million in 2024, then tumbled by 92.02% to $5.2 million in 2025, then jumped by 475.53% to $30.2 million in 2026.
• Business Quant data shows VYGR's Long-Term Investments at $30.2 million in Q1 2026, $5.2 million in Q4 2025, and $20.1 million in Q3 2025.